CBD oil alleviates physical pain and anxiety – both of which can have a negative impact on sleep. Additionally, CBD oil can actually prolong sleep for some, leading to more rest from night to night. Most medical experts agree that marijuana is not particularly beneficial for individuals with medical conditions and/or mental health disorders, as the THC can increase their symptoms; this makes CBD oil a good alternative option for people with the following sleep disorders and medical conditions.
Serenity Hemp Oil is certified organic, made in the USA, and carries the most positive reviews by consumers, setting it at our #1 spot for CBD / hemp oils on Amazon. Larger than most products available on amazon, Serenity Hemp Oil comes in a 4 fl. oz. bottle, and with recommended dosage, it will yield up to 120 days of use. Flavors are orange and peppermint, with lots of positive feedback on both flavors. Manufactured by Serenity Remedies, this product is derived from all-natural methods and contains all-natural ingredients. A portion of proceeds from Serenity Remedies goes to charity as well, assisting patients in obtaining high-cost CBD oil to aid in their health problems.
This means that CBD oil products that are derived from these “not marihuana” parts of imported hemp plants are not federally banned, and the natural cannabinoids in hemp-derived products are exempt from DEA enforcement. While hemp cannot be legally cultivated in the U.S. except under state-regulated programs, hemp-derived oil has been a legal import in the U.S. for decades.
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).
×